Hadassah

Hadassah Physician Receives Hebrew University Award for Research on New Type 1 Diabetes Treatment

Thursday, Jun 14 2012

For her research on a new treatment for Type 1 diabetes, a Hadassah University Medical Center physician has received the Kaye Innovation Award from the Hebrew University. The treatment is now undergoing commercial development.

Dr. Chamutal Gur, a senior physician in Hadassah's Internal Medicine Department, as well as a Ph.D. student under the supervision of Prof. Ofer Mandelboim of the Institute for Medical Research Israel-Canada at the Hebrew University Faculty of Medicine, won the award for her research on the role of Natural Killer cells in autoimmune diseases. Her main project focuses on the function of the NKp46 killer receptor in Type 1 diabetes (T1D).

In people with T1D, autoreactive T cells attack the pancreatic beta cells, which produce natural insulin in the body. Natural Killer (NK) cells, which are part of our innate immune system, kill hazardous cells by using an array of cell receptors. One of the most potent is the NKp46 and Dr. Gur found that it specifically recognizes pancreatic beta cells, which leads to it destroying them.

Dr. Gur, in collaboration with other researchers at Hadassah and Ben-Gurion University, identified this phenomenon in both animal and human cell tests, demonstrating the importance of the NKp46 receptor in the development of diabetes. Concurrently, the research highlights the therapeutic potential of an anti-NKp46 monoclonal antibody (mAb) as a new treatment for T1D. Monoclonal cells are produced from a single ancestral cell by repeated cellular replication and, therefore, can be said to form a single "clone."

Based on the results, a patent was filed through the Hebrew University's Yissum Technology Transfer Company; Hadasit, the commercial arm of Hadassah; and BGN Technologies, the technology transfer company of Ben-Gurion University. The technology was licensed to BioLineRx to develop a blocking anti-NKp46 mAb for the treatment of T1D.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Nov 30 2016

Hadassah Teams Up with Spinal Cord Institute to Study Outcomes of Traumatic Injuries

The medical interventions and outcomes for Israelis with a spinal cord injury (SCI) will now be captured in the Rick Hansen SCI Registry (RHSCIR), thanks to the November 16th launch of a partnership between the Hadassah Medical Organization and the Rick Hansen Institute (RHI), a Canadian-based not-for-profit organization named after the paralympic athlete who suffered a severe spinal cord injury following a car accident.

READ MORE ›
alt_text

Thursday, Nov 17 2016

A Birthday Party in Hadassah’s PICU: Helping a Four-Year-Old Recover

Yehoshua "Shuki" Pepper was crossing a Jerusalem street with an older sibling when a car ran him over. He was rushed to Hadassah Hospital Ein Kerem's Pediatric Intensive Care Unit in fair condition, but he wasn't speaking and subsequent MRIs of his head injury were worrisome.

READ MORE ›
alt_text

Thursday, Nov 17 2016

Ethiopian Pre-Nursing Students: On the Way to Fulfilling a Dream

“I know that some people are fine with looking at a screen all day, but I know I need the human touch--to work with people. I want to be a nurse, " relates Sarah Talala, one of the 18 students of Ethiopian background who were given the opportunity to take a course which enabled them to advance to pre-academic studies at the Hebrew University and then on to nursing school at the Hadassah-Hebrew University Henrietta Szold School of Nursing.

READ MORE ›
alt_text

Monday, Nov 14 2016

Granalix BioTechnologies Introduces Food Additive to Protect Against Neurodegenerative Disease

Granalix BioTechnologies, whose founder and Chief Executive Officer is Hadassah Medical Organization Experimental Neurologist Prof. Ruth Gabizon, has launched a food supplement containing pomegranate oil that has proven to protect against neurodegenerative diseases in pre-clinical models.

READ MORE ›

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Membership Questions

membership@hadassah.org

(800) 664-5646

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Missions Department

missions@hadassah.org

(800) 237-1517

Show More